A recent study suggested that spinal cord stimulation (SCS) may be effective in lowering chronic pain in persons receiving active therapy with a standard anti-cancer medicine, according to researchers at Johns Hopkins University School of Medicine.
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
Despite the fact that chimeric antigen receptor T-cell (CAR-T) therapy has transformed cancer treatment, few studies have looked into its impact on long-term patient quality of life - an aspect of care that is frequently compromised when patients receive traditional intensive cancer medicati
Personalization of cancer treatments has long been a goal--finding the right drugs that work for a patient's specific tumour based on specific genetic and molecular patterns. Many of these targeted therapies are highly effective, but they are not available for all cancers, including NSCLCs w
Analysis has historically been limited by the vast amount of data that may be collected by employing a microscope to record biological activities. Using artificial intelligence (AI), the University of Gothenburg researchers can now track the movement of cells throughout time and place. The t
Some cancers respond well to immunotherapy, a medication therapy that prompts the immune system to target tumours, although results against lung cancer have been conflicting.
Researchers have developed a brand-new method for locating and eliminating cancer cells by using synthetic DNA. The procedure was successful in lab tests against cells generated from human cervical cancer, human breast cancer, and mouse malignant melanoma.
The urge to vomit after eating contaminated food is the body's natural defensive response to get rid of bacterial toxins. However, the process of how our brain initiates this biological reaction upon detecting germs remains elusive.
A variety of intricate cancer therapies known as antibody-drug conjugates (ADCs) have undergone clinical testing and been approved for use on patients. To explain the possible risks associated with these medications, researchers have conducted an extensive analysis of different scientific da
ADCs, or antibody drug conjugates, are a class of complicated cancer treatments that have undergone extensive testing in clinical studies. The study explained the potential hazards related to these drugs.
Researchers found that how pills can help cancer and diabetic patients to manage their ailments instead of needles and injections. UCR scientists have created a chemical "tag" that can be added to these drugs, allowing them to enter blood circulation via the intestines.